Background: Irrational antimicrobial consumption (AMC) became one of the main global health problems in recent decades.
Objective: In order to understand AMC in Latin-American Region, we performed the present research in 6 countries.
Methods: Antimicrobial consumption (J01, A07A, P01AB groups) was registered in Argentina, Chile, Colombia, Costa Rica, Paraguay, and Peru.
Rev Panam Salud Publica
December 2021
This article describes the regulatory changes and procedures introduced in Colombia that created favorable technical conditions for clinical trials of drugs in the country. The impact of these measures was measured in terms of the number of research centers certified in good clinical practice, the time taken to evaluate clinical trial protocols, and the quality of the concepts developed. Using public information sources or data from the literature, the study found that adoption of the regulation requiring certification in good clinical practice and the change in the procedure for evaluating clinical trial protocols contributed to the quality and timeliness of clinical research in Colombia.
View Article and Find Full Text PDF